Scale-Up Strategies and Manufacturing Workflows for Commercial Production of RNA-LNPs
Time: 4:45 pm
day: Conference day One
Details:
- Manufacturing considerations and adaptations to ensure scalability, workflow efficiency, and compliance from early-stage development to commercial production
- How to increase operational flexibility to address novel molecules and expand LNP delivery strategies to new applications beyond mRNA vaccine development
- Strategies to enable high throughput demands required for large-scale manufacturing of RNA-LNP drug products for different therapeutic applications and stages of clinical development